News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

RECOVER researchers and experts from BioData Catalyst® will walk through tools that other researchers may use for their studies of RECOVER data, from determining feasibility to completing the study.
Leveraging her previous research experience in pandemics and vaccination, Dr. Stockwell helps to make critical decisions about how RECOVER studies pediatric Long COVID.
During 2 webinars hosted to raise awareness about pediatric Long COVID, RECOVER researchers and a RECOVER Representative discussed recent study findings, including how Long COVID affects the developing brain.
The RECOVER Digital Health Program used wearable devices to monitor participants’ health data and understand how Long COVID affected their daily activities and sleep.
Recent RECOVER research has revealed important links between Long COVID and a range of other physical, mental, and emotional health conditions.
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Drawing on her experience working in intensive care, expertise in lung health, and knowledge of medical imaging, Dr. Brosnahan is leading studies that could inform the development of treatments for specific Long COVID symptoms.
A study published in Annals of Internal Medicine—led by RECOVER researchers at Mass General Brigham—shows financial hardship, food insecurity, lack of healthcare access, and other social risk factors increase the risk for Long COVID.